David Shook, Chief Medical Officer at Lyell Immunopharma, Inc. (LYEL), sold 500 shares at $12.70 ($6K) on 2026-09-10, disclosed to the SEC on 2026-09-10.
Open-market sale of $6k LYEL by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NKTX | SELL | 2024-06-20 | $3K | — | Filing → |
| NKTX | SELL | 2024-01-18 | $31K | — | Filing → |
| NKTX | SELL | 2023-08-23 | $2K | — | Filing → |